<SEC-DOCUMENT>0001345099-23-000009.txt : 20230214
<SEC-HEADER>0001345099-23-000009.hdr.sgml : 20230214
<ACCEPTANCE-DATETIME>20230213205954
ACCESSION NUMBER:		0001345099-23-000009
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20230209
FILED AS OF DATE:		20230214
DATE AS OF CHANGE:		20230213

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MESOBLAST LTD
		CENTRAL INDEX KEY:			0001345099
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			C3
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37626
		FILM NUMBER:		23621458

	BUSINESS ADDRESS:	
		STREET 1:		LEVEL 38
		STREET 2:		55 COLLINS STREET
		CITY:			MELBOURNE, VICTORIA
		STATE:			C3
		ZIP:			3000
		BUSINESS PHONE:		613 9639 6036

	MAIL ADDRESS:	
		STREET 1:		LEVEL 38
		STREET 2:		55 COLLINS STREET
		CITY:			MELBOURNE, VICTORIA
		STATE:			C3
		ZIP:			3000
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>form6-kxpressreleasecoverf.htm
<DESCRIPTION>6-K
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="if2ecbfa48f9445ba8c0a2a438bd67890_1"></div><div style="min-height:76.5pt;width:100%"><div style="margin-top:0.12pt;text-align:justify;text-indent:0.36pt"><font><br></font></div></div><div style="margin-top:0.12pt;padding-left:21.6pt;text-align:justify;text-indent:0.36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.363%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="15" style="border-top:2pt solid #000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:15pt;font-weight:700;line-height:100%">UNITED STATES <br>SECURITIES AND EXCHANGE COMMISSION</font></div><div style="margin-top:0.12pt;text-align:center;text-indent:0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Washington, D.C. 20549</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:700;line-height:100%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:100%">Form&#160;6-K</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:400;line-height:100%"> </font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Report of Foreign Private Issuer<br>Pursuant to Rule&#160;13a-16 or 15d-16 under the Securities Exchange Act of 1934</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the month of February 2023</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commission File Number 001-37626</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:100%">Mesoblast Limited</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Exact name of Registrant as specified in its charter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Not Applicable</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Translation of Registrant&#8217;s name into English)</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Australia</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br>(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Jurisdiction of incorporation or organization)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Silviu Itescu</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Executive Officer and Executive Director</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 38</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">55 Collins Street</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Melbourne 3000</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Australia </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Address of principal executive offices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</font></div><div style="text-align:center"><font><br></font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant files or will file annual reports under cover Form&#160;20-F or Form&#160;40-F&#58;</font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form&#160;20-F </font><font style="font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Form&#160;40-F </font><font style="font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"></font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation&#160;S-T Rule&#160;101(b)(1)&#58;</font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yes </font><font style="font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> No </font><font style="font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"></font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation&#160;S-T Rule&#160;101(b)(7)&#58;</font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yes </font><font style="font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> No </font><font style="font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"></font></div><div style="margin-top:6pt"><font><br></font></div><div><img alt="image_0.jpg" src="image_0.jpg" style="height:2px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:0.12pt;text-align:justify;text-indent:0.36pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:76.5pt;width:100%"><div style="margin-top:0.12pt;text-align:justify;text-indent:0.36pt"><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INFORMATION CONTAINED ON THIS REPORT ON FORM 6-K</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">On February 9, 2023, Mesoblast Limited filed with the Australian Securities Exchange a new release announcement which is attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit 99.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, and is incorporated herein by reference.</font></div><div style="margin-top:12pt"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:0.12pt;text-align:justify;text-indent:0.36pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:76.5pt;width:100%"><div style="margin-top:0.12pt;text-align:justify;text-indent:0.36pt"><font><br></font></div></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SIGNATURES</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly organized. </font></div><div style="margin-top:0.12pt;text-align:justify;text-indent:0.36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.026%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.622%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.258%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.622%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.772%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.4pt;text-indent:-29.4pt"><font><br></font></div><div style="padding-left:29.4pt;text-indent:-29.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mesoblast Limited</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#47;s&#47; Niva Sivakumar</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Niva Sivakumar</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:125%">Company Secretary</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td></tr></table></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58; February 14, 2023</font></div><div style="margin-top:0.12pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:0.12pt;text-align:justify;text-indent:0.36pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:76.5pt;width:100%"><div style="margin-top:0.12pt;text-align:justify;text-indent:0.36pt"><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INDEX TO EXHIBITS</font></div><div style="margin-top:0.12pt;text-align:justify;text-indent:0.36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.537%"><tr><td style="width:1.0%"></td><td style="width:4.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.086%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Item</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:underline"><a href="exhibit991-.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:underline">99.1</a></font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Press release of Mesoblast Ltd, dated February 9, 2023.</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:0.12pt;text-align:justify;text-indent:0.36pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit991-.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i8154f22fcfa649ffadbe5374777dd6df_1"></div><div style="min-height:101.52pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 99.1</font></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.762%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.398%"></td><td style="width:0.1%"></td></tr><tr style="height:39pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:2.75pt;padding-right:2.75pt"><img alt="image_0a.jpg" src="image_0a.jpg" style="height:30px;margin-bottom:5pt;vertical-align:text-bottom;width:242px"></div></td><td colspan="3" style="padding:0 1pt"><div style="text-align:right"><img alt="imagea.jpg" src="imagea.jpg" style="height:40px;margin-bottom:5pt;vertical-align:text-bottom;width:300px"></div></td></tr></table></div><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FDA GRANTS REGENERATIVE MEDICINE ADVANCED THERAPY (RMAT) DESIGNATION FOR REXLEMESTROCEL-L IN CHRONIC LOW BACK PAIN </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Melbourne, Australia&#59; February 9 and New York, USA&#59; February 8, 2023&#58; </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mesoblast Limited (ASX&#58;MSB&#59; Nasdaq&#58;MESO), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that the United States Food and Drug Administration&#8217;s (FDA) Office of Tissues and Advanced Therapies (OTAT) has granted Regenerative Medicine Advanced Therapy (RMAT) designation for rexlemestrocel-L in the treatment of chronic low back pain (CLBP) associated with disc degeneration, in combination with hyaluronic acid (HA) as delivery agent for injection into the lumbar disc. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RMAT designations aim to expedite the development of regenerative medicine therapies intended to treat, modify, reverse, or cure a serious or life-threatening disease or condition where preliminary clinical evidence indicates that the drug has the potential to address unmet medical needs for the disease or condition. An RMAT designation for rexlemestrocel-L provides all the benefits of Breakthrough and Fast Track designations, including rolling review and eligibility for priority review on filing of a Biologics License Application (BLA).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">There is a significant need for a safe, effective, and durable opioid-sparing treatment in patients with CLBP associated with degenerative disc disease. Data from the completed 404-patient randomized, blinded placebo-controlled Phase 3 trial of rexlemestrocel-L combined with HA formed the basis for FDA&#8217;s determination that Mesoblast&#8217;s allogeneic cell therapy has the potential to address unmet medical needs for patients suffering from CLBP due to disc degeneration. Results from the trial showed that&#58;</font></div><div style="margin-top:6pt;padding-left:35.7pt;text-align:justify;text-indent:-17.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%;padding-left:14.7pt">A single injection of rexlemestrocel-L+HA into the lumbar disc resulted in significant reduction in pain compared with saline control at 12 and 24 months across all subjects (n&#61;404). </font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%;padding-left:14.85pt">The reduction in low back pain observed in all subjects was substantially enhanced in the pre-specified population with CLBP of shorter duration than the median of 68 months for the study (n&#61;194).</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%;padding-left:14.85pt">Significant improvement in function and quality of life measures were observed in subjects with a shorter duration of CLBP at baseline. </font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%;padding-left:14.85pt">Pain reduction through 36 months was seen in the subset of patients using opioids at baseline (n&#61;168) with the rexlemestrocel-L+HA group having substantially greater reduction at all time points compared with saline controls. </font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%;padding-left:14.85pt">Among patients on opioids at baseline, despite instructions to maintain existing therapies throughout the trial, at 36 months 28% who received rexlemestrocel-L + HA were not taking an opioid compared with 8% of saline treated controls.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8220;We are pleased to receive RMAT designation for our cellular therapy to treat CLBP due to disc degeneration&#8221; said Mesoblast Chief Executive Silviu Itescu. &#8220;We look forward to working closely with FDA to efficiently generate the additional data needed to support marketing approval of rexlemestrocel-L for the treatment of this serious and debilitating condition.&#8221;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">About Chronic Low Back Pain</font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CLBP is a serious condition with an annual prevalence of low back pain in the general US adult population of 10-30% and a lifetime prevalence in US adults as high as 65-80%.</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">1</font><font style="color:#0000ff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Overall, low back pain is the fifth most common reason for visiting a US doctor.</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">2</font><font style="color:#0000ff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">In the last 3 months alone, approximately 25% of adults in the USA experienced low back pain for at least 24 hours.</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> In the first 3 months, recovery is observed in 33% of patients, but 1 year after onset, 65% still report pain.</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> CLBP is one of the leading causes of disability in the United States, and it is associated with impaired quality of life, severe limitations in ability to perform activities of daily living, reduced ability to work, and negative impacts on mental health.  In fact, back pain is the leading cause of disability in Americans under 45 years old with more than 26 million Americans between the ages of 20-64 experiencing frequent back pain.</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">5</font><font style="color:#0000ff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Back pain is listed as a cause of limitations in activities of daily living by 15% to 31% of those persons with limitations.</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">6</font><font style="color:#0000ff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">When considering both death and disability,</font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font></div><div><font><br></font></div><div><font><br></font></div><div style="height:107.28pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.614%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.617%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Mesoblast Limited<br></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">ABN 68 109 431 870</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:underline">www.mesoblast.com</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Corporate Headquarters</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Level 38</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">55 Collins Street</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Melbourne 3000</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Victoria Australia</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5pt;font-weight:700;line-height:100%">T</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+61 3 9639 6036</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5pt;font-weight:700;line-height:100%">F</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> +61 3 9639 6030</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">United States Operations</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">505 Fifth Avenue</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Third Floor</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">New York, NY 10017</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">USA</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5pt;font-weight:700;line-height:100%">T</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> +1 212 880 2060</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5pt;font-weight:700;line-height:100%">F</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> +1 212 880 2061</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Asia</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21 Biopolis Road</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">#01-22 Nucleos (South Tower)</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">SINGAPORE 138567</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5pt;font-weight:700;line-height:100%">T</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> +65 6570 0635</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5pt;font-weight:700;line-height:100%">F</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> +65 6570 0176</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#1266ae;padding:0 1pt"></td><td colspan="3" style="background-color:#0f2e5a;padding:0 1pt"></td><td colspan="3" style="background-color:#0f2e5a;padding:0 1pt"></td><td colspan="3" style="background-color:#0f2e5a;padding:0 1pt"></td><td colspan="3" style="background-color:#0f2e5a;padding:0 1pt"></td><td colspan="3" style="background-color:#0f2e5a;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div></div></div><div id="i8154f22fcfa649ffadbe5374777dd6df_4"></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">musculoskeletal conditions such as CLBP are the second greatest cause of disability and have the fourth greatest impact on the overall health of the world population.</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">7</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">About Mesoblast </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mesoblast is a world leader in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. The Company has leveraged its proprietary mesenchymal lineage cell therapy technology platform to establish a broad portfolio of late-stage product candidates which respond to severe inflammation by releasing anti-inflammatory factors that counter and modulate multiple effector arms of the immune system, resulting in significant reduction of the damaging inflammatory process. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mesoblast has a strong and extensive global intellectual property portfolio with protection extending through to at least 2041 in all major markets. The Company&#8217;s proprietary manufacturing processes yield industrial-scale, cryopreserved, off-the-shelf, cellular medicines. These cell therapies, with defined pharmaceutical release criteria, are planned to be readily available to patients worldwide. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mesoblast is developing product candidates for distinct indications based on its remestemcel-L and rexlemestrocel-L allogeneic stromal cell technology platforms. Remestemcel-L is being developed for inflammatory diseases in children and adults including steroid refractory acute graft versus host disease, biologic-resistant inflammatory bowel disease, and acute respiratory distress syndrome. Rexlemestrocel-L is in development for advanced chronic heart failure and chronic low back pain. Two products have been commercialized in Japan and Europe by Mesoblast&#8217;s licensees, and the Company has established commercial partnerships in Europe and China for certain Phase 3 assets.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mesoblast has locations in Australia, the United States and Singapore and is listed on the Australian Securities Exchange (MSB) and on the Nasdaq (MESO). For more information, please see </font><font style="color:#0000ff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">www.mesoblast.com</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">, LinkedIn&#58; Mesoblast Limited and Twitter&#58; &#64;Mesoblast</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">References &#47; Footnotes</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%;padding-left:9.01pt">Urits I, Burshtein A, Sharma M, et al. Low Back Pain, a Comprehensive Review&#58; Pathophysiology, Diagnosis, and Treatment. Current Pain and Headache Reports. 2019&#59;23(3)&#58;1-10. doi&#58;10.1007&#47;s11916-019-0757-1.</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%;padding-left:9.01pt">Atlas SJ, Deyo RA. Evaluating and managing acute low back pain in the primary care setting. J Gen Intern Med, Springer. 2001&#59;16&#58; 120&#8211;31.</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%;padding-left:9.01pt">Petering RC, Webb C. Treatment options for low back pain in athletes. Sports Health, SAGE Publications. 2011&#59;3&#58;550&#8211;5.</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%;padding-left:9.01pt">Itz CJ, Geurts JW, Kleef M, Nelemans P. Clinical course of non&#8208;specific low back pain&#58; A systematic review of prospective cohort studies set in primary care. European Journal of Pain. 2012&#59;17(1)&#58;5-15. doi&#58;10.1002&#47;j.1532-2149.2012.00170.x.</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%;padding-left:9.01pt">American Academy of Pain Medicine - Get the Facts on Pain.  The American Academy of Pain Medicine. http&#58;&#47;&#47;www.painmed.org&#47;patientcenter&#47;facts-on-pain&#47; Accessed on June 28, 2017.</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%;padding-left:9.01pt">United States Bone and Joint Initiative&#58; The Burden of Musculoskeletal Diseases in the United States (BMUS), Third Edition, 2014. Rosemont, IL. Available at http&#58;&#47;&#47;www.boneandjointburden.org. Accessed on August 23, 2017.</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%;padding-left:9.01pt">United States Bone and Joint Initiative&#58; The Burden of Musculoskeletal Diseases in the United States (BMUS), Third Edition, 2014. Rosemont, IL. Available at http&#58;&#47;&#47;www.boneandjointburden.org. Accessed on August 23, 2017.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Forward-Looking Statements</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">This press release includes forward-looking statements that relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. We make such forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. Forward-looking statements should not be read as a guarantee of future performance or results, and actual results may differ from the results anticipated in these forward-looking statements, and the differences may be material and adverse. Forward-looking statements include, but are not limited to, statements about&#58; the initiation, timing, progress and results of Mesoblast&#8217;s preclinical and clinical studies, and Mesoblast&#8217;s research and development programs&#59; Mesoblast&#8217;s ability to advance product candidates into, enroll and</font></div><div><font><br></font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.614%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.617%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#1266ae;padding:0 1pt"></td><td colspan="3" style="background-color:#0f2e5a;padding:0 1pt"></td><td colspan="3" style="background-color:#0f2e5a;padding:0 1pt"></td><td colspan="3" style="background-color:#0f2e5a;padding:0 1pt"></td><td colspan="3" style="background-color:#0f2e5a;padding:0 1pt"></td><td colspan="3" style="background-color:#0f2e5a;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">successfully complete, clinical studies, including multi-national clinical trials&#59; Mesoblast&#8217;s ability to advance its manufacturing capabilities&#59; the timing or likelihood of regulatory filings and approvals, manufacturing activities and product marketing activities, if any&#59; the commercialization of Mesoblast&#8217;s product candidates, if approved&#59; regulatory or public perceptions and market acceptance surrounding the use of stem-cell based therapies&#59; the potential for Mesoblast&#8217;s product candidates, if any are approved, to be withdrawn from the market due to patient adverse events or deaths&#59; the potential benefits of strategic collaboration agreements and Mesoblast&#8217;s ability to enter into and maintain established strategic collaborations&#59; Mesoblast&#8217;s ability to establish and maintain intellectual property on its product candidates and Mesoblast&#8217;s ability to successfully defend these in cases of alleged infringement&#59; the scope of protection Mesoblast is able to establish and maintain for intellectual property rights covering its product candidates and technology&#59; estimates of Mesoblast&#8217;s expenses, future revenues, capital requirements and its needs for additional financing&#59; Mesoblast&#8217;s financial performance&#59; developments relating to Mesoblast&#8217;s competitors and industry&#59; and the pricing and reimbursement of Mesoblast&#8217;s product candidates, if approved. You should read this press release together with our risk factors, in our most recently filed reports with the SEC or on our website. Uncertainties and risks that may cause Mesoblast&#8217;s actual results, performance or achievements to be materially different from those which may be expressed or implied by such statements, and accordingly, you should not place undue reliance on these forward-looking statements. We do not undertake any obligations to publicly update or revise any forward-looking statements, whether as a result of new information, future developments or otherwise.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Release authorized by the Chief Executive.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">For more information, please contact&#58;</font></div><div style="text-align:justify"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.675%"><tr><td style="width:1.0%"></td><td style="width:48.820%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.980%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Corporate Communications &#47; Investors</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Media</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Paul Hughes</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">BlueDot Media</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">T&#58; +61 3 9639 6036</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Steve Dabkowski</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">E&#58; </font><font style="color:#0000ff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">investors&#64;mesoblast.com</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">T&#58; +61 419 880 486</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">E&#58; </font><font style="color:#0000ff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">steve&#64;bluedot.net.au</font></div></td></tr><tr style="height:10pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rubenstein</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tali Mackay</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">E&#58; </font><font style="color:#0000ff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">tmackay&#64;rubenstein.com</font></div></td></tr><tr style="height:10pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:10pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.614%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.617%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#1266ae;padding:0 1pt"></td><td colspan="3" style="background-color:#0f2e5a;padding:0 1pt"></td><td colspan="3" style="background-color:#0f2e5a;padding:0 1pt"></td><td colspan="3" style="background-color:#0f2e5a;padding:0 1pt"></td><td colspan="3" style="background-color:#0f2e5a;padding:0 1pt"></td><td colspan="3" style="background-color:#0f2e5a;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_0.jpg
<TEXT>
begin 644 image_0.jpg
MB5!.1PT*&@H    -24A$4@  #=\    +" (   "[H()%    JDE$051X7NW:
MH1$ (!# ,$9G\^>P2*XRD9VA:P,            0F9GU-@            !^
MN3,!            2NY,            @)([$P           *#DS@0
M       HN3,!            2NY,            @)([$P           *#D
MS@0            HW3MS             .@<OE"AW0V/M0@     245.1*Y"
"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_0a.jpg
<TEXT>
begin 644 image_0a.jpg
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M+=R*J[Q&8):05@-/^[1E8*[0UN=#EI8I@B[LYEX5:%H[["L.ZIVLJ5[56R]
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J\9",DT@DQD,R3B*1& _).(E$8CS\#PQ5Y73#PM4D     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>imagea.jpg
<TEXT>
begin 644 imagea.jpg
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M3:6T<AP#0*D@VGNNHP+/2B(2 D._1$1$1$1$1$1$1$1$1#,7 \"G9_02SP8
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M#8)5MXF(B(B(B(B(B(B(B(AH.IL*P54%P'1U=87_^2L/?JZA:?:]F4S2*.4
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M.4<I91 $A6F:4X5)W.^X90-:&RIAM $G 1,1$1$1$1$1$1$1$1%-7><: '8
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M2G/%>FRQ?C56VF?ZI\DRNIUE$=3]2]/I>'FEURJV#XJ/X[5!-'6-+G?'RCN
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M(,J'&XIJ5VQOQ%6'RTS?T>/=!W>Y+IY*B#P]N^K0;QY]]/GC8[RE"[:U3D8
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M,[@$;O,ET<J6MU6NF/NC67'[V9[=/__O@P</I@O/8SD[V7WV%S89<3>&TPT
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MLF1334M;YUU:^Y!@Y"S1"51A/V W[.)_O_E:+&ZO@\YY# +3#"$B\('8@F(
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MF+.' *"ON.G=;]_5G?Y/L.?Q&<P'^0O[$?)0KNZTH_?,7__F+_M_"@3>LR,
MJ#D-*U:^V&O]J]^$@3-)X4(@4JPTI<J7?FWV[,4U"!1QKQ8!0#=><L.=>_K$
M?:P91*0+0-$<, $,&!#D#B?=I9VZ[,'++[^U%$%6B)PA:/0,*;7NU@]_IF=$
MWTIBRI3;/.ZE 1[_XK.^^*Q_&_T^G7[M?,#WWB*T#_,_-UU^VQL1]/N PH4
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M:RTA31B6 4/04!&E^M*QKN-2TAX)9U]U1!R:XW2T[]I^I"^&81= ^H2?PAD
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MC)/IQT^LHQXE2Y:MN#B52DV61TG #$;ZZ:"7-%3AX2^]!9<NF@N5L&$$1N"
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M%[QS2<##:;IT.&5<F@.57V8T,+VT<'Q1P<_71 2E%,RJI1?C\)['G;*FN]6
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M,Q$KEP &$:EQT<'Y#!&1RXYKE,QMO+&[9=-#&#MS+)B /0B JJ^OC\2*JM_
M PX@\\\@EDE5!F% &@*6<#NKP\Z3)6[7[UL.OWC(ED;[X5-'NS.?SQQZNJUM
M]!(7.MYX>TM++X!> (< ;(X=!SKW>'\LJ:NKU#$]O[&A<1[-FO_:$W'C9EN;
MJUP-@G(! >6?(9P/,BB1(#>93)<LF+/P1M\ G%?/>Y+1 #!K7M/JP7XGDXH_
M;S(#$:"9M0!)+"I7#QBQ+5]NV;\[DZYX_)FU^:#$F*@N!$!V=Q\^-<NAMU<M
MO>:IWA%>3X)4'JS/! 8<$NL6+$"XK>VTC-DS#0T ?2GQ3G])+(@YP,_\H'VO
M0 !$)$T0&(9@5T"?-$EU2*$/S2NFDSW]7<>*:Q;VS)%=:<<UT]MW/IUTE9LB
M FM+OD3AS;8RR#"$:Z="34N:HK4K5UG[#_6$RC!8RR5SYG4,\GQ#FHVVYEH7
M1HW2GN67M?+%8#]JV.OK^=ZF1$2NDW8BHF;!=0">RG6%9C($5JPAJTJ-_XGT
M//L1OW@FIB9V <BAH:&!99'>C[6[\_\GD=:EOK-%ML:4 !@IA*]=MO:VI0=V
M/]J"8&\0D&<41Z.7Q+6&'XV:I:@\U@PIZ_30-]KW/?-S!.F(,R@ :-WU]-.5
MZ^?]MH^L.P#6R,Z^C8A(V8Z.U"U8NK:K?5MS%JXY76  &$BIIDF8@ADD**3B
M+^S;]=BN\?<+&(4!()WN.5)M\A^32=Q%!)6EXV (!#B,M0B<3 (FF=,Z[-WO
M^LS%KF-+(N&>^;> @,E$$$$S@XCPE^^Z&G55I;CGNW_ 2-*&$3;AJIFVIPN8
MAC  Q9H-  B%PZFH=%K)[ML6X>'?AGED:W_[H>'^_OYX)F7ER7%?=G#VL*7.
MUA/H;-WN_7NL.%);NRY:45]5UYT0-SI&Q2UNN'1MW.9JV&E "H7\-$YZ&E8!
MG24EN": 6;,$"83#5KS8< Y2LG=S1,4?KI:)YNT[]L<2Z(V=\H6[(^.^G)C@
M@@-#P!/']XTO,E>N7%GB1FL7]:3";W=#E;>F.+S"3J4E))B0]2CFK..=^\CH
MC%FWEL]9L&"PJZT-IQM19CH2@)LPY]R>2,G5$ [R+/J7X:<J*XI&7.D,/ELC
MX_\E^<13+9NW]V8^Y,\A+Y<&-QN+[42I/PF &CEQH@] 7^N+)W< &QZNKJ[^
M:N/BBU>>2!2_+UE4]<9$2M4Q% @B'XQ@ (B@%>+ANM>AJNK?T-L[4]*C9\X]
M-8;MT&)D@O?R! (T:RU"H9 JUYV?.[+ID:_[?S+@U;L0A,;,F6IF?W_K<$U/
MQ?\7K;STR7@\&87(VIEJYPL!&@X5557,OGI16]N&?9@9_?Y,"  WKKFNO@/1
MU_KG"^;U6@[/0NW)FB2$$0HA(IR.L+"/VB-]6ZJMU,;BLLCN5->!D0,'#B0
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ME!WK&X PP5D,QQ9$B)JB.%O7"PB8B%$#<*@H_!I! LCB(>X! 1>*$-ZYP,S
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MQG,*@T'1$'7+Y,'_XY=--T-8!A< TEU['YX=Q2YP[B(B&2 0,&R;\RMJ5S3
M&Q?3/?)+A@3F^__.Z1S 8, PH>/=K4>.'!G"]$Q1QO ,&Z@VTL?]M3BWOY$(
M"4=%AFQ9GM-Z3#W>\4AE=BW(O C(C]3_ ,!@089$A3KQUVW[]G5A^AA_QZ,
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M5!O*;?0+\D+QG0/\*+"[I;*JET&YGO(WMQ5B@%!AIG_3NG-GCU^<1WTGJS
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M=;[)'P0H5FPTE*B'VC9OVXS"-[YH &C=^<=-Q9?4[;8I='$.HQM'821"-O
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MQ6?_KW8A-E" &\]=IL&:=;9-=!P\M?QSS+Y];00 NP9[R_.3&MR@F>P$)H8
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M(4Q$Z.[*X?ZN'.Z/_L[S I0<#_/%&L:G\CAT>@I'+R[@Y*5%S)0=E!P?52]
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M35D+CLMY3@-(0*"EA85I0&M!IPZGQB4B\"48&BU^;G<<IXQ. @>:0+'%90
M+*R.Z#]CWS=6 0- 9]J;95(O [BOT0,--X+K*?-=K[LFNC^^Z.'CN9[>\]UW
MW_%,?[9Z6#NYTPN3+TT&U9E9RF:G2I,GYO#ZTI@U^KMLZ>-UO?*"[\TP'0>0
MB;\8"P,]:2XY6=\M%NM;6A(#0+%6FM$YK9"0<Q$ 0-.&N)O0C%RE+\3=AG6.
M 4 (KGHJ6 #0]QJO?\-OSS+3T]CW-(RFL9;W!JW:+V@E#$ "TY7^K'^P4)5O
M!4&CP7TA!B0$\X5*]L<WW_N^(^>>^:O_%OV5@)F091CKGO5__^(O?;R]/2N
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MUJHVQ&K,-&\88D""HY6!1!S-C&>RP6 ?@>=1.)V.A0+9 .R &3400#E $AP
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M]J7I_NZ]ST*V[>15^MH8$"2%]GU?+'+/+V]^Z*?O2A6/?>+4H<</1B^I3X0
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M&:<V>Z0R,S.-RP?M3)JV-T84W4!").'#TH!(HU"\:%8 +PLDP0OB_W+"T?A
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M8L-,!$MBKERY5@KPEI.SA>MZ<;<BJ@<?^-@P.I@V >"&80"DP>A)4*WG=8P
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M1A/0K(/9<NET]-1<Z W#, QCM3"0MD2F,V=U1EM:87") 8B3)Y\]<U.F^"E
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M"9P]]AD G]ER\T-W7JK1.P<V;+MO477<7G.K&SC RG7 ]2#RE0=>_ =B"V*
M( AY-]A)@MX,X,MHODF'X7&<2OFU0#D@$?N!343008#A_H'<Q,68&Y,0>_8@
M=88H[:],)A\SRQ*>J0+<6$R,V<F<"2PTR$AG5]NX4B 2C2P"'!V!YFLRUH0
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ME1,G[LN>EVD"@ # <JD%>J_J6O#NHQ6+.\I,!]P\&5"(R609N%NGR]74$@*
MHFF-.(JZ+_7EJSE]2I:/S\R<GH3GJ!?-N5=T(0!0BV<>-22!F07T6*AI7!0
MB.RQWTM+>PR@H-L[ 8P*S#5G6H8VG)=I-,&@)]4:31U!@ L&6F+\I-61/.V+
M]21+H]%H@H,!H%06XQR!C0 " &:TI\SV2WU7H]'4!=5T8B[.1P@[)Y_ZYA^^
M_Z;.]TEEG6/%@LA+KQ<AO(A4&*EI<V5KV,K4"LOYKUE7]0#DA)WFF@! $O?'
M)3?L_;X24G%SG5]B, )K'Q,&S>:!_Q@!71J/"D3'^O7K=;FR:R3O6O&\[;:
M*."2)B:(9@JZ_6MJ# & [<IUC"4#<"#MF,$$(>!62L>".%\S,S7YTO&DZ>X%
M$T76@5&CN788@)@Y?7"R"_D_!5$MHM[981G+JO2[_&-ML],$AFY,&DT=P6!
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M#D2\:\075+-%:9H/!<#&^1)2U_*Q 3@ZK8Y&4R<0P,R".LW*L2V;NG^\9Q*
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M*3HT&HVFMC  9.W*?(K4#(!>> ;7<&HP$E@IA5BR=5-IF7Y-PI*QHX)T"JB
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M;>O27ZQ/%)/!##"3$>9',4DP .4>\%5KNG8/P+%<G/;_'GKK9P V-VPJ;@:
MU>U\5A)')=L.NP!B#MWD'S?=.[#ZAEMNJ%@<)XK"V,<,82#FS(SY KTVJP4$
M569*#RMWK2_1^U97R'31VJ8XV/O&2@&Q. J31T=]D6[_&HT& " $,N$FS&I,
M:*D?)PFOSPWB P"2.:&?V#5@&'DF4F[ &;,( )3KIN%6 DPMK:D7>GIZXDPB
MT.A\2R&F)](:391AHF1,+5+F[)=\B?;0TF@TFNM$)I-9B(%'JT[H8>G! $$
M!8<&9^=YJR]NICF< B#RY7('2/CV^# A ,I63(UJ!(L,U3=O97OEU')1LY$P
MC7PD]MC]\!O+<G-AJU(C&  R,Z?.F>3DP^[[ 8"( -N&T36X8<N6+3'XA7##
MU.DZP@!PBEMN"RBPXIIA9F'$38R?.7/6%X6O5.-!1*10J2 ^O&V5+XM !U@W
M$ "L'$GN4"4&B<#V#Q@,&3,%YA;FJ@9@W?XU=8M0;$*WX<!0+G?JGEK3)#
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M_*TWWOF^>WU9H,:=B"  J"V[/_;&$_/.QR )'*'KC G.]2>LE_S#1FS_48+
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M)B*X$1JS&X94G,H&,< 4:(U99L 5QLK SMF$)#OZMRG'!0)T3L^-Q&D  "
M241!5"& H5QTM;94LRTU4K:QRX-!@:][F>$(LZ-[V[8.7Q*!=?5K(  P33$@
M_+V 0$[(0+O).@)8HXD(S$H9J9:DXID#?PHOLL) LW7T&HU&$T$.'CR83W'I
M7T&1, ![Z3"%<.<KSIV)M??]B2]6:*Q%MP2 CAO>_*EL1>X"128*#()8I6-H
MZ!2@,2%/^C<[[#9%($;!%H/4M?H!7Q;(@BC"" #V\/#VS@5A?@8.@R+0_LF/
M!V^3S@N^*.RV44L4 )2*N:<EW"EX!;$C\:XS@R")YV7OIP=N>>#S\"-PX/69
MD>@CKP()[QK$ZCL_^E>G%^GC@*O\^QXITJ+PJ/_7R.G6B#  L(LL==S8N6K3
M=C2.PT/0"  079OO+*O81O_.!1C]RU)(<A.%T8,!G5.CN6SFYZ9/Q4P)* [,
M&:NZHG.E7#,\O+T37M]2KV-H6"@ >&7"_F4_1;&^?\'" &#;SJRK%$ (SAF1
MB-EVT-K6I5.@7SD$O^V[9OL(E ,*LND3""S1;N8RRWZOJ7 9EF+E!GCIGEV=
MC/2D6!EYIP<2\9Z@_#W8[YHKMG5"+UPTFDC #&DB84U_>^',OA_ 6\1I[W*-
M1J,)'P$ +0GZ1_\X$D8  !(,/EM,_&+/33_]1[Y,P3..U?M"P0#@]*V_<]V!
M*?XMT-(%1>*Z#%*YP;A]P#^,2GL("O]ZW%-1N30"*79LY!,K?FUX^_9.>/.C
M1EW#++5Q8_4M_V&A8-](@MP(U$!E+ZI#H3?-QT/6Y7J@ &#3JO3AUCC&O=C/
MR$  B%V')ZW6SW3O_MAW5JW=>0.\S6N&]V[4@S%8X/Q[[*[?=N>Z]IL_\8,S
M^>0G(8B! "-=KAT&LXR9E,M/'&J&]A\E! 0Y^;+=F^P=>9<OBU+;B H$  79
M]0G;=H7O-!?4B144T)V4SQ\X>^1$4.?5:"X#!0 QPSTD2,TCP+D?^P:!O&L,
M3Y7Y9E\<]ERKGI  ,'+3V]YN&VUOJT'6 4W5!TK(<0C*7.K+5P+YIZ]P;+B_
MOS\-[0!Q)1  ;AW<N+%044.!YZ97BD0\AM,GCC5JN:E+4G'LO.VHRE)##0BE
MR"Q6W)W^813OJS>7L^RJ8\8U7SL1 &8,=2?/Z Y:HXD"#&%*+L9S)W\_;%4T
M&HU&\UJ2]LPKAD 9"-#[-A"89YW6W^S>_9&_WGK''5WPC&.$^MW$,  X.W?>
MW2'ZMGVI5.&5$4HIQB"!&)5/[=V[9VY)UE@P *Q(QXX)(CML90"O\"!)X4XM
ME#<YB>W_T1<3HKEPNQ8(?KV[G??\_"=/SKN_!B$0 >,OX!G *!4W)@X=V#L9
MMC+7 08@]^W;9[O9R?TP37#47G4B8M=1<Q7SW;F>V_]UZ*;W_OKNW;O;X6V8
M5S?R#$2C[ZQ2U:F:[EEA<#"U\<X'/C/3LN-?,V6^'\Q5W2/S?E<-8*F4>'K2
M*9[RQ1%K$(T+@0B. SNY^H.=G9WM:&PGH*M! G ';KAI<R76_5:HZC0P,!A$
M:.7<CY#-SF-YNG:-IK8H " ACYI2!5V*AR"$8U4JJ8'A+;N69)K+P<L\LF5+
M; Y#OUNIV 0BW2<$#P- &FK6)+< #J[]LS^U*:GX:M$VN-L7ZW'U\I  L&[#
M37<5*^Y*" HR2Q,#D(8@Y5JEB66R9L$K@2Q%QI!&*>!+5PJ 1;$W^L=1;.\$
M /TROEU57])KA1F0!FCRN;-1O&"-IJD@P 4$AE/EOY@XON]Y^)M_8>NET6@T
M&@#^S//@N0-'VV+J"3\2S U;*1]OL:&4FK-2'Y]0VQY9M?6M]^.\ 4#"&U.B
MOJ%1-7P) ,Z&&^]9.=NZZ5N3F<J;$8WHQRH*1(BQ^S"\NLM1OZ]7 P. M7!X
M-$96(2)UK\&  #&FG=1G5NQ\Y\_!3Q<;MEX!4FU+[CL_\H:??G%"?AY2 !&9
M#Q*@P(04V<]EIL^.^N+0VT6-\2(OG.RWI2" (]C>B 0(;J90[AMS>__;8=[Q
MS.H[?^;3/8,;-\)K.P[.EP>H?@BU-[#2!9_J;[.OD[MF\Z[5&^[ZF4^U#=SW
MQ)%<^O.97'D%$44TO2\SI,3:_,R/,3Y>A"[3<UUA0)(D=R;GW+QRTQON"5N?
MJ-*Y:O?'\KEB/PD1I(&<62DCEDCPQ-E7]OJR1IS[:*() Q"9T5<6TBH[#A&L
M#RX!@*M@Q]KN F"B<>?V04, L+I_Y[_+6^(.$(=>IJ1!\>:AJ=*X(%H,^-Q$
M4KBE0KEUQ?".:D1D].:YT8/@[P/-VZG;P*IJI O. ,R *=5L:X)/+LF:C)&V
MED)[7%A!9F B(K!MPVSOV^*+HA;U3@"<+5NVM.3;5P[!MCREKPUFADR8Y!P\
M=6Y*O^ :38@0X+)BV9:DD];LWC\-6Q^-1J/1O 8&8&!\O-AEB*<B. <G$ F
MU7S!W3DA1WYPPYL_^;?KMM[U!G@36X7S2DN$;Q2N&@.JN@">?@J ZM]TST>F
M8FL?&YLKWPTA(V4,J)I"!Y*Y/<M%C<C)DR>SY)1?CE )3@(1.Y:+13GT_ZZ[
MZZ,/X+PC1F3:R%50?1<8 &^YZZ._\H^O;/DJ##<%IHC5]2:TR/QS\#9(F\$
MQ@"P)FD\;4(%FGHO8"2$8%8N%RS:>"8;_Y_%@3?]:,U=G_KJ\,ZW?:IO_>YU
MJ$;;GA\/JA_@U7VR@?,1NI?[J7Y_^;C"%WP4 +5RY:;NSK6W?F3HC3_WES,M
MMSQZ="'^A6Q%W.096 5'R-EG.<R*#21B%7ORT-Y+?UU3"Q@08.!4I?>S\-I<
M))QC(H  X*[==.N&$XOJ4Q"$@#.F,$!(D'LH$<\_[,NBX@2I:0X( /*9N<>%
M(0$.;N[-@(0D3!;X;6NVW;5Y^>]I+HH!P%VUZ:XW3V72O\-0U?JG^K[5!IH_
M?CS;)NT,F/Q2RP'!8 C"N3R]&=ZXH1T@+@T!4$/KMZV;+M&[_0<2\%J-8 HU
M:502QWQ!,\UWO$QDAY_-L)TK@>22+) 30Z&@DC>D5FR]!>?+YD0% 0"GYGA;
MUA&#OB_ -;V/U?["%.JXP7+6"$)+C49S53 S$QF$7K;_Z,21(^/P4U^&K9A&
MH]%H7@4#P,+4\X_'.F\I6A4[!2)&M!9)@@C*91;'9M1'X\G-[^V\>>V/V]7T
ME_N,N7]Y]MEGY_#J33L!;\P!7FT4 *Y]HDW+_KPPVJP:D;;$&]_XKLXSB^J^
M0J+WT_.<>I-=K( ,X3)'RAB@F%DF8C@W>OR50V$K4V,( "=C>*90P9O@/:\H
M/ N"(%6N6(F3%>-OAV]_8/7HTU__+S@?[0[4S\9T-16N#0"M@QMZNM;<_@<'
M%XU/0CB(F/&7F=DPXZ:;FS[Q2MC*7$<8 %YXX>&)]IL^\E294O?#*W(7E>>R
M'/+_8P!NL>(,G"KA8S#7?*RU>\/4BK8M)T5IX7F9Q!,"LR\/]K9/G3UPH#0V
M-E;!JYV$@B*V\0UOB#M63P=7LANR:+U+)-MNS7)JB\5R:&&^+$ V2)##U>C@
MB+H3$, ,HA5D'2RUV(_XXGKI9QH) A27E7G;P/;[/S'QRC]] 7K=O(35L?$W
M*P7T$ 6;-86(P:Z)X>YS3^[?>S(#/]UT4.?7:"X#!0 =">>A,O'GU/FU2Q 0
M :[K<D)TKODIX(F7T?C.;=>" < 96K][7:Y]RU?*!2M)@A1',4-*8^ YH0-.
M87'R-,6'[F#'(EQS4.#2R24$,%\6[UAS_P>WG?JG!U^&OP8,Y <:F%C/AG>6
M"[P" 6>N(0!,A!8NC8V-[RNB^<9<!B#W $Y[7,ZC$&@!'D&"G%+9Z=HRM.9M
M!R</[$4UG7TT$ #<D94C;SIDNYW^&NE:QSL%ADB:V#]=G)W4!F"-)C2804)T
MFO8C)Y[[ZE_YPJAT/AJ-1J,YCP* N9,O_*CGCCM?F2U5;B,I^5J]\H+&WTAG
M,LBM5.QT!?*^K#%TWY2]8K+_#5O_I7?FR#^?'3MZP!7&V7Q^<@87]RBM1H2]
MSD\L_?M%5+BT(3F=[NM/]?8,;-Y\T]9#,^X]+Y22]Y4-8Y5;=@"402)RQE\0
M0;'#8E5K[*'C4V=.H;$7R 2 5\2=?;-E@ @<H0L51*08AA@MFG_8?\<G[EIC
M3/^'IY_X_O/^OR^O31@AM0&<?V^JBTU[<' PU;?ASO<?R[5_[DP6&P'%Q,01
MJ7D-P#> *45M*7$T/6M7BU\WRWQ5 %#]2?E@QL+]$7L77@_/L8!(D81BY<A<
MWN[/4:P?\<$[A(O_4]  9F;5'/4.G.CN<\XZP,DU79@1F;.SQTZ=G2G9E9)!
MY#BNLAW!%;S^>T2&H(3!PF 6L;[!%>F^OMZ!+/=T3>:<(2F-=:,E8PU#K+*H
M+\X@<-Z!Y^]@@:27HC: C8WK  -"(NW,/WO\^/$*FF\S+CH0L>O8E$D,_\Z:
MS;L>.G7HA3-H;B.P <#9<.N[WW^T:/Z"E^DOV+D3*XA8BMB>+OZ=+VJF2"1-
M-/#JH%;&#R:-U6,YB!%?%L@:K#K?FBB:O[!KUUU__L(+3\R@L>?X5XL!P.E;
MLZU_OGWG-PMY:PT)BMQZK0%A "!5>8: CP2\/B "7,>EI,BE/PQ .T#\9 B
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M=?=,S<Q\-Y 37SL$@ <WW';S=('?!H$@'/J8F:41CV'BY.']0!TMOC2:1H(
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MS25A #APX,!\STT[GBI2^CV "GH.2F"%!3OUT9Y-;WEL]O"/OH#&'T^O! G
M[NM;TU_LVOG_Y0OE%A*B%N\!@P297-Y[].B^N259\\$ T&:-[I]-K*RXA$3
MYQ<@Q7,5><? SO=\>N+%[WX>X3K\2 #NYIO>_?[#!?E!D *#KGE_T5O:"4BW
M>&+\U,M'X.5HTC0'I&?LT8#95=),Q.SVXHG?.C8_GX7V+M1H-)IZ00!0UM3+
M7Y2=MWS4=50-,O_4',\8S(#OO,U^2E. B+VY@@,HO-KGTOM[-9KL_'3B@B4H
M"6_/@'WKP++[(^K$6'XA#(!:8WQV1VO\RT\< =!$!K#%\<,/)X?O_DRI6$CY
M)7BBV. %0'[V<,7*<44>8@ D/[4PW_>IQ(I!-S:H7NF+T<EVSI^;'C\Z[CK.
ML7C,&$W"7BPNYJ=V[%A5W+-GCY_#]M+3Y;OOOMO8<_JTT66W]:1:DEV+!;=+
M"75##\Q5YNJM _...>"XO&[>$9LGYFT_:34#<+S7P[^7$3?^>K6O&7*HI?S%
M@\\?M-"<!@ 7 /)C^[[=,WC_;\YFG4TD2472(R(X&OG:+A?%S#(9D[/S$_M_
MX,N:L?U'%"(0U%3)?6_7\(X]JSO,7SJS__$G_7^LSC4:9:RN&GY= .ZF6]YU
MYR0-?F6QX&R 4$&FPEU" $HI1^QL:?E?/_SV5T^@>0UAFFC  (SY^?ELU_21
M!Y&\X4YV[4#78 Q((G+GB[AE8/"^K_08CSZPK.Y[,QC"EO<S#(#[;KCMWDS'
MEL^=7I1W>24>*&K9@)H% 4"EX_3=69O?4RV>%"!$0BB[7!;YEHU_/+Q-G1K=
M_]C#_N]6,QLU(]6YA-O2OZZO,O3F_YTI8@=JYP3!($*OR#^8;>X2D0P !P\>
M'$ONN/$ D-X=O-,#,5R7YF)]G]MRR[V/'=S[\(OPH[R#^XW+P@#@W';W.U8=
MS _\,;,#(@HFP(29A!F'DSG^N"^A2&\Z: +$96*]E \?9D6&*;MYZK\=>^&1
M?X&N+Z+1:#3U! / XIF7_G75\.T/C<TY;R>#G'J)9+T(KTIGR\M%KY?H]L*C
M"^86C;8[0H#+(*/#G?FS)Y[XX0R:QP#@ J#\U($?=0S?OK\$NA7!IARK!:]*
M>PZP(F(N5RI&F;$S6^"=TQ2'V7T+ .4X@G)E*,MJX\*+)5%>\88-#BG;*A=*
M-KLN&R15T2WG8L)L 7D+_41+VA2&:1ZT#3/>O<$L0:4J,I:HI#DA""VC3,!<
MV8N ]S1B/UJ"\.I4YU&^CU44*R73J=34N2-/_(,O:Y;VOQP&($='1Q=ZNZ;^
M@6+]O\V.'=4:\)J \*)_2:Q,%KY^_/F73Z%Y-^*BBI=.1 AW/E/9GH]O_.<-
M=XU\OGQFSY^,CHXN^-\QX8UE]?S<#/B&W_7KU\>++=M_]:3;_;N6Y;34,!)/
M*:6,5#J979QZZ6N7_KI&<UWP:J$6Y[^!;N-7YC/6&M\9*S#G4@8D".Y$WGE?
M;]];OI=<$#]?FCMZSO_GZKO8:',@ 3_"$;Z3QYJM;[RQD%SUV2QU?K!<+,<@
ME.M_KQX=>1N&V<-/[4VL?5NQ7'%27C*MX-82# @20I7+E;:9V/J_VWI7SR\>
M>.+!!_U_-N'M63=:V[\8R]\)K-UZYRVSB8U?R%2P$P07M3/^2KAV8<>Z[B=/
M/%>#7Z@_5&="/%HJ8C=1X*6H!(A<RW*[QY-#?[WAQCO>=?2EI\[A^AJ!#0#.
MX.!@:ERM^D*N8*TC4[K,P66V,.!6.E*EKV>]8U7/&Y::*Z C)9W9K T(O5D1
M%N2G4NI*\9/&V7V_YXOK>4&JT6@TS48U':@]D,Q\94RFW\[,!J)O&--<!02X
M[++1VQ%[:?' HU\Y+VZ*!3##C_@QLF?_7B37W*H<JYZ,7@1 >NF/R$M[[OLW
MV)4B 638S)W5NJB+-@/LVV5EBS]?9B#6AJ):E@TWIP!V "R;4W-Q>=I<15)4
M@T.]5.<1C_*]& 163(9HL\?_=F+JV$DT=P28 @ C<_0+\8Z>7RJ#NL)62%-3
M%"ME)-.IW,*YYZH&L+KI_.J<*YI/,2!)"->RG/11R_SMMKZW_=103_8/%R>?
M_%YN?'S6_YK$Z]=\CRI5)R$_;030?\/M;\OT[/C<;$&]B1T71+5+P^K5!I=H
M4]GOG#SYX^>@LY5IHH$"(,?&7CJW?O76OYNGQ&_7*!.'!+,[DW7O;1FYZ[&A
M-5M_Y^QSW_H&SI<!$#C?C]1#?W(A=,&?7O:;D9'$RGC_':)KR\?'BN+#=H42
M4"74*-6MYLI@ "@LG-K?GQ /E<MX/Q$"+R'#@" BMU11W4?1]8W5MWST#PJG
M]OV7V=DC.?\KU6CX)9T:A-=])U(]/8.#&]_^\;%R\K/E"K>#E(L:U;XFP&5'
M&4-=YD/?^L87#_KB1KK'5XH H-JM\<<FQ+K?X%J4 O:S/BP6^4;;W/C@AAOQ
M0=\(?#VR/A@ G)Z>C:WYWNU?RLZ[[R!#J@"-OPP2E(#UTNA+/SY2E6D/GB8A
MU658J,8?:*X[!"A6+!*FS#KGGOG,V-A8":^>/&HT&HVF/G !T-Y__OHW1M+N
M8_!V'W1?WG@P,TL9-Y','?O]3":S &^RWDR.6PH 5G2X7TU*MQK]7(\0>\9@
M@P$#)"2(&$)XJ9B)%(10)$F1A"*X"G"\/Y6M $<!K@)<10+^]X0"D?+_7P8)
MKUP/B:7?\3?,ZO*>$:#89:,E:<[84X>^$+8^$8 !T,2I0V=ZC-Q?^0LJ;1!I
M6!B0)A+6[/?G3K_\#)K;^>'ZPB _N>5ESZN\J#UB$*ML&1O.VNU?3JQYSR-]
MV]_QN<&1[9MP/@JX>DZ"]TPESJ>X#(NJ0:FJ"^ [$P'@MM6[W[7RSD_\_5S+
M]H=G<LZ;F%T%(JZE08851#HE"]URZ@]]D6[[FJB@ "!F'?OS]K0\!^8:.662
M!$'E+5XW9G7^W< ;?N$'ZW>]]:>6Z;#<F20J?<F%5!U)7J]_J?8Q:F#UMLUK
M;OD__EW_RON_-YG:\>C9''W<=CD!N I"U+2OT5PV50=TY<X=>8@,$\Q<D[UD
MSZF*E&TY\DPY\3O.NKL?7;W[9S\Y.+@[A67IP?VO1[7M7XSE[\-%WXE=M[[]
MQCL^\&O_B5:_YT?'LXG_IUQ1[2!6M3+^PMMS$!2+066/?]?7PX3>7\*AHZ\\
MWYZ21Z$@J09[,-7V7K#IMNGXEG_:<?M]M^%\.P\RZ\'RM@< SFWWOON&]-:W
M?#?KMGT(7H1SD/99!2+T)@I?AK=>%4"=>J1KKAREEL4F:*XWS/Z-W]97^;^?
M>^&5?= ;"1J-1E.O5">$C-R9/Y#FNKM<QQ5U%!FIN2Q8 4*NB.7_9O2%1[\)
M[YDWF\&' =#^9QZ9&KG]@2\7K/1G">S4:T3K!;PFP3E?\$^O-V5NEFDT@T&F
M@;0U]H6I\2-'H.>M@!^1ESV][XLM:^[]1+Y0Z241;/I)341@B)BABNG2V3_P
M<PDWD^-/J"1-++J0<<MVDU<XK_)+ 'CI_V<6RCM@#NUH[1OYE?:V'<^G1.9!
M63SZP[&C1Z>Q+-7ILO_7P/FHVPNCA8/H^I='&"V/(KPPK:;<LF7+RGQZP_NM
M>/\#<T6Z.9NI&*!J73BJ:7]#@,,DC%:>^XL#SSQR$,V3]413'S  <7#OWLFA
MW<._GT''7Q"X5G5I!0!F!D\LJ'?(V+K[NV]=_2(59KXWF)SXYLO//7<,0 77
MOR]9SH7]2E5OX+6.+P" 54!R]2UO67NXG'JWF>Z^-^\FMT^4W3X4RH D]NM/
M2M2XK]%<,0H $OF9;W9V;?ZW\XO6!DA2J('AE;WTN #@+N:MFQ>E>7/WT*Y_
M.S@P\IUX[NS73QU]]C!>V_:!G]SV@=J.)1>NZRXLN:-P\13NZ5VWW;;Z;+[[
M[93J?,\A.[6C?&"^"Z8!$#M^&:!:O@\,AF@SW$/%$Z/?]F7-MN=P(0J 1'%V
MHI7R#R\BJ+=8$   ( !)1$%4O@'>\PO\.7CIS\E=+*AMY?CJ1X9WO^_W*V-/
M_?>IJ:F"_Y7J\[_0 >)25.=ZU1(RU??%'+[I?3]_8+'O]_*YT@HR9=!9%A28
M9<+DB=F3>_]Y^3\TP@:.YDK04_@08 8)L:K=_IOG'OKJ__"%>B-!H]%HZA<%
M@$X?^-%#@[>L_)MQ-_YQ NL460T" 2XKR/:T/&1/O_P;OKA99T\$@#MX_$MQ
MN>$7*@[W@*"@C5X-BU?[%*(S*0\F)\_^B2_6\U9_,R([<^)XS^"-?YX7G?^)
MH6J4@5(3%G[==_G_MW?G\9%=Y9WP?\\Y=ZDJ56F7NM6MWMMVV^T5,-AA,^\0
MP+R9)!,(3(! 9H80YLUDF9#D#9F0-_-.\F:!9+),R) %!S Q@6!PP&"\T<:+
M<'>K]U9O4K=:^[Y5J;9[[WG>/^XMJ5I6+^[6KN?[0<A==6M1U5GN/<\YS]GL
M9O_FPN&6XY"KYR5#I%"C1SZ5S_N[QU33KX!]'Z!7.UY% #1I%7#@(3U=;(2.
MO6L*R7>YR8VYBKM?_W)C2CV?R/4?/-=QZH+K<U\ZW3N**P^VSEW=="WE8>[Q
M<]-FE@8"*5Z[J9F-VKGYMA]YW4C!>4<'Q]Y<*% <TP5 $4B1'V6Q6.S@;\ !
M6[55[KG,\1<^,WNSE'^QHC  =(^V/K2Y^5WO[QW-OY5LY3,ORMAVN)^')C_P
M/6O4QSVPFNY)FPV?BM]SZ^'&A'J6)\Z]W-5YKCU)JB^3&1S"E=N24D#@%7_/
MM;Z7.8^;+QWO;%"NOC[E%F,;4BEW2^.N>VX>R"1>/\%TWW#@W%I01$C[ (J
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M%$OM;![,Z\V WCX58,O(F!_^)0#  4 <;H,2+O54-_39E7I)I0A&3A<7D0&
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M\]XM?S1)]9]%&'%?[&#E*\L^P3!\SF;]!("[,UG</435L.L;P<S(*THS!P6
M,MTQ*C;<=WLQ.Y7.&O;2<4OE88IISZ?I?& FF5E;6DV2TI.7I!XW;)B#ZL"@
MD@F^14C$;4H!Y&A+IZ:+[ :L8ZED*M7KN':AP;:*!>/XQ FE+#<(3 Q$MF<(
M;2,%0!5G_R+% >EPDA46H4Z\"@90NH['_[ G7/TKDVYGS6R[%LL-_*7E['B;
M7RPN]K9K83D@,&""S'1N9X82.^U-/_*1'(*1 0?CE7??-D)>;B#P@Z%BH/JU
MK:>8 ]<$IL[5NL&-48.*5VP8]6MK&5Q]/J]JT%< = Y$R@?XQB;<7.G-$\!>
M@#MV5?YSZV//',.<<2P)  NQ.)C9**5=;(OU_M)+SWS[ &0000@AUIH @!IN
M?_&K-[WIYM>>*])OAE-(94/@58B968$(=V\RGSC\Q&-?A%R$E1@ NKV]?:IY
M;_,GI^R;OAWXOHY60TA97R.BU>]6I95Y*CER['?+[I( \*4" *K]T-/?VW[_
M>S[=F:[ZK2@MNJP"7MT82M'VRORGS[6^\ VLSWW?EQ4SX/N( 4#?\>\\M/VM
M/_>6SF'U<Z2QD-E5HH$W E28HH\ !CSV"D4%P/8952"JFLP7$79QM8!6T?P^
M +'9S7LOE\LR#92248,#@^R$!U#I^1@@&"(*H!5Q*>"[3&-S1 @X(%U3Z1XJ
MGG_I-Z[^""%6A   ^HY\^T\VO_D_O;YWC-Y#M*!MQ=50M%<NH,*E^V%;8N 5
ML@1 !XQ*$%5Z149FF@"* 58"I**Y=0QP,OS/*[4G0-0910>P!O(> X6H72&"
MS\72_0;$AFP-9E IL+58[0L1? Y@-:;,UW<-'?UT?_R^CT/;T8I*L0@8 ,X?
M./+0AOO>]M.#:7H;*?A+W']<INP'[!6R"H#V&2D0I0"N'\H!@ :L.I!2R",*
M?UFS97R^\@^\,K=YH?R@6%C,1@L!D O"9U&E2E(L[>EA0&R4K9@Y#/"&::Q(
M+W<1)<!G ZNI*GBJYZ5O?"&Z62K.I0P =!]_\K'*NS_PY!3B[P!X*;:B(@ 6
M*668C/$*60VF^D*.ZZ%K;E)V'=CB<#ERJ<@QX %(,P%3 8!<^#2*F6P*P$HM
M<CUE-E"QA#4T>N:Y3T>W73*.)3/WA5@4S% 6FF,3GS[;\NW2(/)Z7T$DA!!K
M$0/ N1<>^JWFE'H8K%0XW5JL%@08,!,IPIX&ZY.'G_C'/PMO?L6>0NM9 $#U
MG-SWQ$VI_!^$$[19/I\U(MS[T>@--?$3;]I<_/FVMK8B9 +$E3  ;'='/]5<
M8S\.PYHD6+AJ$>"#C:J+!=^R!_?_3G2SM&U+B\/LH5[]S"T7C_S7#5760086
MJWXIA'M>6@RR02K,XJ)4F.Y2*4.*#)1OP$7#OA?^&(\1_?"<GTMN]SW#?M$
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MXIUY_&<:4U8+>&8EL'QNJT28*HX-F'1U',?B?3]X\/R)%P\BO&!<"2MG5HL
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MAB2U. ,M_V;X_,%2VF=IG\1:$0#0_1=.7=SJ'7GGME3A'Y3E$!N6ZZ\;0$#
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MVY0[_D"CG7NX(N&,L&&+S<R%M*S$N'ZE@?P #,4!6[:MIIHJU;]L*;:_8_#
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M[M\9;GO\#\ONEG,=(8005U(>"*:^]H.'T7[P<#*YX:]ON?V-]PT5[0\54/%
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MT!H9.9,>&3GS]\W-]W^YHJ[RWWM+P,WB   ;U4E$052IC1^>\A/W%G+%"L
M*IQQA-5;?TJ3@)B9%1MHV+9V$TXN[D\=XJD+CVUQLU\\T?KR8'1\:36CI#M?
M.G+]M++-;,MSX<*)05PX\5>OW;3I'WHJ]_R$26[\4-ZJ?D,ZZ]>%?2_*5P6O
M]DE8\UU/6= V*F+6Q6H]=4!G>[_098U^+W.HM92 P4+8OEZM_R0 &,\5JRB@
M^ *^W]7\>:\D/J+2W-%Q; @=QQX!\,CNN]Y^S^"T^6"\?L>;)WWWUD+!2\'X
MI9)N",3K9*SA:N8?BR"M8PF7*RQS,FY&]YNIH4?Z3NW[_MG9^E*:@"[][](H
MG0NJT8N'3N'BH0\T[WGSYZ:<C9\PR<:W9]+9.!1%*X)7;)O.0"GNQ!JD546%
M.VSG>KZ2R'9\^L+AF4D%U[V-C02 A;@&X0PYHV/Q&#<&W;_2=?CQOXKNDE0.
MBXT-P P0+V<^&0K#_+S2.HE%%!"8 09%:2>6 P'K[$K:&"J=7RX;BCYW9J"X
MXDZ,UIK214)I-J+IZ#@V!. + +ZP>?.>NDS.NW?SIJVO":IVW3-55'=[ >_V
M?-:S&P^8\O+"(##-3N"8&T2;^]_+Z=*!_9E;>78%*!&!5/A7$<&QR8M;YFB-
ME3\PT7^TQ<]/'ASJ/W<* "9GGW?FLUR*/T)<E8]+]Z?A<T?V'0%P) .@8L.>
M.[2V7[=UYQUW#Q82]QA6=V6+7,FE80<NM8>7EO'PI # RB[C\RDO]T TFD!$
M8%-6]DN!/J4 @!@$VR(XBL]6Q\TA-77N1%]'SR&GRCH\W-DV  #CLZ]1GNY<
M!AY6GE>T^VUM!P8 ?&D"^-+6K7?49/+^ZW;6;=@;U.VZ=SBG[@A8[RWX1D?G
MPT!0RF@V6R^BB4&E+WXU!(HOJ0M<^EW>!S#"M.:*B U@V0J:N*LF9HXDS?!+
MW>?/'DHE<@<Z.SLGIF:?5\K_4@K;Z(4H7P0P F.T5RQ6O-IW@=F^AGIZ6G+H
MP4, 'DINO..MV[?O?7 @J'QWNLAW&%/:/6)FPI&)SIEHGGJS'.:>&U'T^5*4
MYI^8 =L"$G%K?]UXQS-3@UU/C0R<V0> HW.A\CH@DQ^6RH*.5RQ8O1*O9*(?
M!8!;^_JRZ.M[!, CU9MVW[.Q:OO;N7;WCXYE@Q_Q? [;(A.4G9U1*:/02FDS
M2N:T'8R9+7(07D<!BJ ("9L&JESSK#U]?M]D9^>SO4/M'67/4VH_KK7_) #8
ML&'#YC[/TZ"9=/37C\+^@$GJP *Y)#L3 --^].G#  YO<6YSIH;]-]S<O./U
M4^[6^Z=\NC_O\R831*7;E![* ,!$8(ZNP=9(@+@4=./9+I=G4\%35'=8$8@0
M<RB3<'A_M3_\<N^%TRT5"?N%KJ[C99=@,Y^)]+U+[Y*4_SVGGW\.P'/UV^]^
MH&[S'3\UG'??D_6P"1Q=1X4!X;F3'9:R')>R>J%\*R=FUA4)JS,5C'PUTW7F
M"Q,#)]LFPN-O>!L;"0 +<14$!&R,MAV[4%=L_UC7L:>_.'N7## O-K(<0#NS
M:X&6":^SA=Y:N^'GKDTI'K@,&,P$K?4RO?[24Y;%2CO1F>CRG4<S&2C+83@V
MD+WZ\>*&E?<EI8L.ZNT]/0K@B=ZQCB> [VLDZALWUR0WU.VXZ\ZNZ=B]!9_N
M(BN^BY5=4S04 XB"("#V/$!I1*G,9L.KB@R!@G"@G4$4!I:89R_>RDL=7\=)
M,)6N$*.GB-;:<&DH(II-HYA91P<1,\V\DK)=$#$LQ7DW\,8<,WW.N&AM\ =_
M>.;D@6.N@Y'.='JT["5+J:J"Z&6E7UYY+HG@HFQEZO3@Z>, CG?T'0=J:RO=
MZ:!AUY[;MWKQ36\8S:F[2=NWPG:W% .K(F!R *+ \R@*FUY:Q@D@4@; 3!E'
M:="++PV*4=D;P_5?[/&<YYF]C<!13>!H_@*!F9A911,:B$V4O904. @ UX%6
M"HK8MRC(.2H8\@KI=E?Q\>VIZ=:^SH,G!D>#T>GLR$#I)8?#(8=2)UD:E)S[
M>8N5:=YV/QI(>NK\T*FG@'U ,MGHP*F_>^^]-_7[M6_(!K@SEDS=DLYQHR&5
M\!D6H,CD\QIDP*3#IZ;9\!$1!0@'.**V/SJKYMD)%#?:]D=_1-E,C=E!-8J6
M+#( (B(PB(W1T8.(31C;8@!P7(3Y_=E+V)SQB]DNXP?'ME3Q_M&._?M')P=Z
M!W*Y80!% (@V5RNM5"JO V*1V; !RP&, =&-9]4CL#$^J[VWW5Y]\@=MX4VO
M3OEWKP&8S,#QY\X,''\.J=1G;MYYVYY)9\>[<^R\RU>Q6PJ!2@2!I]@O+0QF
M0)$!R"<P(;SZ+!_<7J@3\YFZ$4U\" >>B<#,&M%D((8*QP,M!Y8R7DS[HUXN
M?6!KRCPSV+[_!Q/>Y(7)B8F)LO=76O$N=6")*3NL"[,+1F\,<W0=1I9\CXNG
MO _6 'BBK_TP^MH/ Z?_5WV]V;IA]^ONZ\ZEWFW%8_=G?-7HLW9-OJ! %$T_
M9(#($)$?Q82),7/O8@3&YFD[HKK.1G,4\&4.SRV58X/ )F&9M#+%=NUG]FV@
M@6=/G3A^(IL?[YK[]^,&^M"JJMNK^](%*,LM;>ER8W\H,91Z-<D@Q#68>]ZI
MV]K:B@">/SM\]GD &K&:S;N;FS>KQMON[TWS?78\>5?!J$T^ZT3 I$Q@"($?
M%1 S4[J)*&"0F3G'C*Z[2C4%2S]1=]Y)AM'DB-(L8Q6NM$0T%J+#\QG7@2*"
M)E-P?3-NPYQ5=OKE.C/TXID3AT[D*YW!L>'A# !$E4C.05>62R8\C'0>V3?2
M>63?YMV[_V3'QKO>/)B/OX_MY!LG\J;>&"@NEC(^,$A1 ":#,"H\-RA\W>,%
MF&V[PRUL  7#FIDT2$$[-EP53'$Q?6!7;?$+ YVM3P]<O-@?/;YT;G?#8URK
M=9:&N'8:0-#\X'_Y3L^%](-PM(EF@HEK0(2  Z.3R<1X,GWZ@P-MSWX79:M8
MEOGMK0=4N^M-[TP'N@D$OVRL=:G?!H-)*_8&"Q=?? )K^[LG +S]SC?>USEF
MW1&S32[  HSJ7-];81BV8]H,I<^_\%VL[9ET!( K-N^]*XAMN"<P0;!\Y3V<
MZ!QS+)X>.O@XIJ;&2N]ON=[/.E:^#\^\,[%ON^TV1\4J=_5ED[<5_.#F6*)B
M2ZI^V^;)=*;1=BIJ)_(FI8AJ?*B87_2 H!BM'-/A%PTNI3F;#=V6ONEY+]7F
M%DM^9<G@Z/G"Y5Q14AX5!NJ" % :ENO (N3!/%IE%R=]J$'7\@<F!WHZ;?;.
M-%;2$9/N/MW>WEZXS.=22FTK_?'J50IZE0+X\U[8W'WWW=494[UGO(A;"K[>
MF:QIV.8[3@,5N,%W4C7I?%!I:UWE&;A^OC#[-,H.RQN;V3)>*I/SE?%+_CU?
M\SNGK,]]CE((S925>:T ]J/YR#:LN V;V/.#8#+AJ,FX*DP%06&HL3HYUM?3
MV^T5,ET;$NJ4ZP^TM;6U#5WN,\'L)%YSA6/$ZE2^%[9WF6-HV[;7;K2JJFX=
MSM.>HL];F[?LV#)I8G6ZD&V<UO&J0C&HTDI7%@/80;$83I:@:.Y%>=N/:'AN
M9J@,\]2+RYV.7*%.7%(?**P+!, / *7@Q&-09')L>*S2,5.^*0PTJV X.]37
MU:_I0IWV3C17>R=:6EK&+O/BI3I0Z@?$T@G/"5.INECCZW\L\'P#O0#GK &Q
M=BS'C+>_5!R]> HWGFFK--GH%2LF[G[#6V[J&.*WVLGFU[G)Q"W31F\M!%93
MH>C%80* HVZI;(+1;,0G+/@T\Q*7_D>D- ^N-->M]'\T,S^I=*YD.)RT9WS
MLN$Z=MY19C"!0J]%Q?-3XX,GZ]WB2[7.],'6UM:YTS)+^Y1*/5@>!(";;WW#
M38/Y^%L!+MSX]1LQF)5E6T4U<?S[T\/# Z7768#W*ZZL5)\NN>9Z\,$'W3-=
MDW=.!!5OKFQJWIOU>7>AX#;G66\L>"8!KP!0U+?JJ$[/A VNI]V8;3DN;3M
M,^>PI;:#5-B_.S$XEO)LXI&$SO=YG+M8&!TZFU#FY3T-WOX77WRQ;YZ_U\:-
M!Q84 %.]Z;9[IMV-KR-X.;[AL:.P#KB6SF7:CSX!C$U!ZL!BF9F B/G'&M2=
M=[YATTB0>,UTP>S=':_:T9NL:_8#-.4H7N<'7&>@$EZ^$%UO*2 P8;%741DM
MO<JE]0$HZR?#0RZI#E<X\2S_QRLNZ,J"=CQ;LBDJ/H8 '?6WL.'&;<,<I!..
M&M5!>K FY?0-]O9VV:;85NUDCFR8T"=;>EIR\[P/Z7M7C_( /0#@G3_]T[4O
MMW8_X,<;WY9JW'#[U!1MSQM[<Y OV-!F]EIH9FWPW';\R@-CEY[WL;ID.D)T
M?>2X;KK2#;J,2;<5QP:?VZ+'OGWJU.&+9<]5FN"]8&/@$@!>^R0 ?'T88(,
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MBIMV[ZJ-5VY(GI_(V8XWO;&NJKK>,VY\:-J/%WV3@J)J5Y,+TC$B91<#MKR
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MME]M&=? ;@N8M)'*NXG =9B-9C8: .5Y;CG7MN_M>D794[%>TW%V,E_(NP"
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M@,5Z9(C '$#''#6V2??^QOF7OOOYZ#X)_@HAA!!"""&$$$(((8000HA52P+
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ME;OPV$1/]U='NL_T1<>6IWJ6?7Z%$$(((8000@@AA!!"""&$*",!8+%<F("
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M[3][J&LX.SV0GAX>Z+WTI77TVV VT"SIG8400@@AA!!"""&$$$(((818!!(
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2&WYS=U"Y     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
